1-Bromo-2,3-difluoro-4-(trifluoromethyl)benzene

Catalog No.: 
ACDXYK802
CAS No.: 
247220-84-4
Molecular Formula: 
C7H2BrF5
Molecular Weight: 
260.99
1-Bromo-2,3-difluoro-4-(trifluoromethyl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$73.00In stockInquiry
250mg97%$114.00In stockInquiry
1g97%$228.00In stockInquiry
5g97%$958.00InquiryInquiry
25g97%$3756.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Bromo-2,3-difluoro-4-(trifluoromethyl)benzene
IUPAC Name1-bromo-2,3-difluoro-4-(trifluoromethyl)benzene
MDL No.MFCD00236264
Molecular FormulaC7H2BrF5
Molecular Weight260.99
SMILESFC(C1=CC=C(Br)C(F)=C1F)(F)F
InChI KeyMCORQPVVYSDQAE-UHFFFAOYSA-N
Synonym2,4-DIFLUORO-5-(TRIFLUOROMETHYL)BROMOBENZENE;1-Bromo-2,3-difluoro-4-(trifluoromethyl)benzene;Benzene, 1-bromo-2,3-difluoro-4-(trifluoromethyl)-
CAS No.247220-84-4
PubChem CID2737082

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDXYK802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPYSO392 route compound structure diagram
    ACPYSO39264248-59-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDXYK802 route product structure diagram
    ACDXYK802247220-84-4In Stock
Inquiry

2. ACDXYK802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDXYK802 route product structure diagram
    ACDXYK802247220-84-4In Stock
Inquiry

3. ACDXYK802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDXYK802 route product structure diagram
    ACDXYK802247220-84-4In Stock
Inquiry

Comments (0)